These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8998201)

  • 1. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.
    Tasch RF; Goeree R; Henke CJ; O'Brien BJ
    Pharmacoeconomics; 1996 Jan; 9(1):61-75. PubMed ID: 10160088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G; Huse DM; Delea TE; Colditz GA; Richter JM
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-the-counter histamine2-blocker therapy.
    Gonzalez ER; Grillo JA
    Ann Pharmacother; 1994 Mar; 28(3):392-5. PubMed ID: 7910767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists.
    Shaw MJ; Fendrick AM; Kane RL; Adlis SA; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):673-6. PubMed ID: 11280532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
    Shih YC; Prasad M; Luce BR
    Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumer usage patterns of nonprescription histamine2-receptor antagonists.
    Shi CW; Gralnek IM; Dulai GS; Towfigh A; Asch S
    Am J Gastroenterol; 2004 Apr; 99(4):606-10. PubMed ID: 15089889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.
    Hunt RH
    CMAJ; 1996 Jan; 154(1):49-53. PubMed ID: 8542566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?
    Menees SB; Guentner A; Chey SW; Saad R; Chey WD
    Am J Gastroenterol; 2015 Nov; 110(11):1516-25. PubMed ID: 26054623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
    Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
    Sullivan PW; Nichol MB
    Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' views on the over-the-counter availability of H2-antagonists.
    Erwin J; Britten N; Jones R
    Br J Gen Pract; 1997 Feb; 47(415):99-102. PubMed ID: 9101694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of over-the-counter availability of histamine2-receptor antagonists.
    Feldman M
    Arch Intern Med; 1993 Nov; 153(21):2415-24. PubMed ID: 8105765
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonprescription H2-receptor antagonists.
    Marsh TD
    J Am Pharm Assoc (Wash); 1997; NS37(5):552-6. PubMed ID: 9479407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
    Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
    Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential public sector cost-savings from over-the-counter access to oral contraceptives.
    Foster DG; Biggs MA; Phillips KA; Grindlay K; Grossman D
    Contraception; 2015 May; 91(5):373-9. PubMed ID: 25732570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution between prescribed and over-the-counter medications.
    Leibowitz A
    Med Care; 1989 Jan; 27(1):85-94. PubMed ID: 2911221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.